sulpiride has been researched along with remoxipride in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (12.50) | 18.7374 |
1990's | 12 (50.00) | 18.2507 |
2000's | 5 (20.83) | 29.6817 |
2010's | 4 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angeby-Möller, K; de Paulis, T; Florvall, L; Hall, H; Johansson, L; Kumar, Y; Ogren, SO; Rämsby, S | 1 |
Hollingsworth, EB; Kelley, JL; Norman, MH | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Arhem, P; Elinder, F; Ericsson, G; Sandell, L; Westlind-Danielsson, A | 1 |
Budygin, EA; Gaĭnetdinov, RR; Kovalev, GI; Kudrin, VS; Raevskiĭ, KS | 1 |
Bissette, G; Levant, B; Nemeroff, CB; Widerlöv, E | 1 |
Eneroth, P; Jansson, P; Movin, G; Nilsson, L; Ogenstad, S; von Bahr, C; Wiesel, FA | 1 |
Gerlach, J | 1 |
Fowler, CJ; Magnusson, O; Mohringe, B | 1 |
Angeby, K; Florvall, L; Hall, H; Köhler, C; Lindbom, LO; Magnusson, O; Ogren, SO | 1 |
Perrault, G; Sanger, DJ | 1 |
Andersson, I; Gustafsson, K; Westlind-Danielsson, A | 1 |
de Angelis, L | 1 |
Ahlenius, S; Ericson, E; Wijkström, A | 1 |
Liu, KL; Lung, FW | 1 |
Rammsayer, TH | 1 |
Hillefors, M; von Euler, G | 1 |
Basta-Kaim, A; Budziszewska, B; Jaworska-Feil, L; Kubera, M; Lasoń, W; Leśkiewicz, M; Tetich, M | 1 |
Díaz, E; Israel, A; Silva, M | 1 |
Bastianetto, S; Danik, M; Mennicken, F; Quirion, R; Williams, S | 1 |
1 review(s) available for sulpiride and remoxipride
Article | Year |
---|---|
New antipsychotics: classification, efficacy, and adverse effects.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Humans; Isoxazoles; Piperidines; Receptors, Dopamine; Receptors, Glutamate; Receptors, Neurotransmitter; Receptors, Serotonin; Remoxipride; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride | 1991 |
3 trial(s) available for sulpiride and remoxipride
Article | Year |
---|---|
Neuroendocrine responses to single oral doses of remoxipride and sulpiride in healthy female and male volunteers.
Topics: Adult; Antipsychotic Agents; Benzamides; Double-Blind Method; Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone; Homovanillic Acid; Humans; Hydrocortisone; Luteinizing Hormone; Male; Neurosecretory Systems; Progesterone; Prolactin; Remoxipride; Sulpiride; Testosterone | 1991 |
New antipsychotics: classification, efficacy, and adverse effects.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Humans; Isoxazoles; Piperidines; Receptors, Dopamine; Receptors, Glutamate; Receptors, Neurotransmitter; Receptors, Serotonin; Remoxipride; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride | 1991 |
Are there dissociable roles of the mesostriatal and mesolimbocortical dopamine systems on temporal information processing in humans?
Topics: Adult; Arousal; Attention; Basal Ganglia; Cerebral Cortex; Corpus Striatum; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Double-Blind Method; Flicker Fusion; Haloperidol; Humans; Limbic System; Male; Mesencephalon; Neural Pathways; Psychomotor Performance; Reaction Time; Receptors, Dopamine D2; Remoxipride; Sensory Thresholds; Sulpiride; Time Perception | 1997 |
21 other study(ies) available for sulpiride and remoxipride
Article | Year |
---|---|
Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides.
Topics: Animals; Apomorphine; Benzamides; Chemical Phenomena; Chemistry; Corpus Striatum; Dopamine Antagonists; Humans; Hyperkinesis; Magnetic Resonance Spectroscopy; Male; Rats; Rats, Inbred Strains; Salicylamides; Spiperone; Stereotyped Behavior; Structure-Activity Relationship | 1985 |
Conformationally restricted analogues of remoxipride as potential antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Benzamides; Drug Evaluation, Preclinical; Male; Molecular Conformation; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Remoxipride; Structure-Activity Relationship | 1993 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
High concentrations of the neuroleptic remoxipride block voltage-activated Na+ channels in central and peripheral nerve membranes.
Topics: Animals; Brain; Cerebral Cortex; Corpus Striatum; Dose-Response Relationship, Drug; Electrophysiology; Haloperidol; In Vitro Techniques; Male; Nerve Fibers, Myelinated; Potassium; Rats; Rats, Sprague-Dawley; Remoxipride; Sodium; Sodium Channels; Sulpiride; Xenopus laevis | 1992 |
[Different effects of typical and atypical neuroleptics on K+-stimulated dopamine release from isolated rat striatum].
Topics: Animals; Antipsychotic Agents; Carbolines; Clozapine; Corpus Striatum; Dopamine; Dopamine Antagonists; In Vitro Techniques; Male; Metoclopramide; Potassium; Raclopride; Rats; Rats, Wistar; Remoxipride; Salicylamides; Stimulation, Chemical; Sulpiride; Thioridazine; Tiapamil Hydrochloride; Trifluoperazine | 1992 |
Alterations in regional brain neurotensin concentrations produced by atypical antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Benzamides; Carbazoles; Caudate Nucleus; Haloperidol; Male; Neurotensin; Nucleus Accumbens; Radioimmunoassay; Rats; Rats, Inbred Strains; Remoxipride; Sulpiride | 1991 |
Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzamides; Benzazepines; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Haloperidol; Homovanillic Acid; Male; Olfactory Bulb; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Remoxipride; Substantia Nigra; Sulpiride | 1987 |
Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
Topics: Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzamides; Binding, Competitive; Brain Chemistry; Catalepsy; Chlorpromazine; Dogs; Female; Haloperidol; Histocytochemistry; Humans; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Remoxipride; Spiperone; Sulpiride; Thioridazine; Vomiting | 1984 |
Effects of typical and atypical antipsychotic drugs on response decrement patterns in rats.
Topics: Animals; Antipsychotic Agents; Clozapine; Conditioning, Operant; Dose-Response Relationship, Drug; Haloperidol; Isoxazoles; Male; Piperidines; Rats; Rats, Wistar; Remoxipride; Risperidone; Serotonin Antagonists; Sulpiride | 1995 |
Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Calcium; Colforsin; Corpus Striatum; Cyclic AMP; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; In Vitro Techniques; Male; Pergolide; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Remoxipride; Salicylamides; Structure-Activity Relationship; Sulpiride | 1994 |
Ascorbic acid and atypical antipsychotic drugs: modulation of amineptine-induced behavior in mice.
Topics: Animals; Antipsychotic Agents; Ascorbic Acid; Clozapine; Dibenzocycloheptenes; Dopamine; Female; Mice; Motor Activity; Remoxipride; Sulpiride | 1995 |
Stimulation of brain dopamine autoreceptors by remoxipride administration in reserpine-treated male rats.
Topics: 5-Hydroxytryptophan; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain Chemistry; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Dopamine; Electrochemistry; Haloperidol; Hydrazines; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Remoxipride; Reserpine; Stimulation, Chemical; Sulpiride | 1993 |
[Difference in prolaction response of schizophrenic patients to equivalent doses of haloperidol, remoxipride and sulpiride].
Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Female; Haloperidol; Humans; Male; Middle Aged; Prolactin; Remoxipride; Schizophrenia; Sex Factors; Sulpiride | 1996 |
Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzopyrans; Binding, Competitive; Caudate Nucleus; Clozapine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Guanidines; Guanosine Triphosphate; Haloperidol; Heterotrimeric GTP-Binding Proteins; Indans; Kinetics; Magnesium; Male; Oxazines; Protein Binding; Putamen; Quinpirole; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Remoxipride; Sodium; Specific Pathogen-Free Organisms; Sulfones; Sulpiride; Tetrahydronaphthalenes | 2001 |
Chlorpromazine inhibits the glucocorticoid receptor-mediated gene transcription in a calcium-dependent manner.
Topics: Animals; Antipsychotic Agents; Calcimycin; Calcium; Calcium Channel Blockers; Cell Line; Cell Line, Transformed; Chloramphenicol O-Acetyltransferase; Chlorpromazine; Clozapine; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Estrenes; Fibroblasts; Gene Expression Regulation; Genes, Reporter; Haloperidol; Histamine; Histamine H1 Antagonists; Ionophores; Mammary Tumor Virus, Mouse; Mice; Nifedipine; Phorbol Esters; Phosphodiesterase Inhibitors; Protein Kinase C; Protein Kinase C-alpha; Pyrilamine; Pyrrolidinones; Raclopride; Receptors, Glucocorticoid; Remoxipride; Sulfonamides; Sulpiride; Tetradecanoylphorbol Acetate; Thionucleotides; Transcription, Genetic; Type C Phospholipases | 2002 |
Role of brain dopaminergic system in the adrenomedullin-induced diuresis and natriuresis.
Topics: Adrenergic Uptake Inhibitors; Adrenomedullin; Animals; Benzazepines; Brain; Catecholamines; Chromatography, High Pressure Liquid; Desipramine; Diuresis; Dopamine; Dopamine Antagonists; Injections, Intraventricular; Male; Natriuresis; Oxidopamine; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Remoxipride; Sulpiride; Sympatholytics | 2003 |
Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation.
Topics: Animals; Anisoles; Antipsychotic Agents; Benzazepines; Butaclamol; Caspase Inhibitors; Cell Death; Cells, Cultured; Chlorpromazine; Clozapine; Domperidone; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Ginkgo biloba; Haloperidol; Hippocampus; Indans; Isoxazoles; Neurons; Neuroprotective Agents; Peptides; Piperidines; Plant Extracts; Propylamines; Raclopride; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Remoxipride; Risperidone; Sulpiride | 2006 |